Article Archive For Keyword: Pharmaceuticals

Download
Article

• A Statistical Analysis Of Vertex Pharmaceuticals

  ARTICLE SYNOPSIS...Before taking a position in this security it is important that I first look at its technical condition. In this analysis I use linear regression as the analysis tool to determine the overall trend of this pharmaceutical company and when to time my trade.

AUTHOR: Alan R. NorthamDATE: DEC 2010

Download
Article

• Enzon Pharmaceuticals Bottoming Out?

  ARTICLE SYNOPSIS...From the slow but steady build in stock price, it appears that something is in the wind. Whether it is the potential launch of a new product or other positive corporate news, this could be an interesting technical play.

AUTHOR: Matt BlackmanDATE: MAR 2004

Download
Article

• Falling Pharmaceuticals

  ARTICLE SYNOPSIS...Looking for a bear market? Try the companies stocking your medicine cabinet.

AUTHOR: David PennDATE: NOV 2005

Download
Article

• GW Pharmaceuticals A Buy?

  ARTICLE SYNOPSIS...Here's a company worth looking at that could be a long term hold.

AUTHOR: Koos van der MerweDATE: OCT 2014

Download
Article

• Millennium Pharmaceuticals Bouncing Off Strong Support

  ARTICLE SYNOPSIS...After a big rise, stocks will often languish sideways or correct down before making another bull move.

AUTHOR: Gary GrosschadlDATE: FEB 2008

Download
Article

• Millennium Pharmaceuticals Moves Off A Bottom

  ARTICLE SYNOPSIS...This stock is ready for a bounce, how far can it go?

AUTHOR: Gary GrosschadlDATE: FEB 2005

Download
Article

• Millennium Pharmaceuticals On Upswing

  ARTICLE SYNOPSIS...This stock appears to be coming off a bottom, similar to a double bottom in some regards.

AUTHOR: Gary GrosschadlDATE: AUG 2004

Download
Article

• SciClone Pharmaceuticals

  ARTICLE SYNOPSIS...Pharmaceutical companies are not the most popular investment vehicles today, so why are insiders accumulating this one?

AUTHOR: Koos van der MerweDATE: JUL 2005

Download
Article

• Upside Targets For Millennium Pharmaceuticals

  ARTICLE SYNOPSIS...Close to multiyear lows, this pharmaceutical company appears to be in accumulation. What are the possible upside targets?

AUTHOR: Gary GrosschadlDATE: APR 2005